Great Lakes Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
18,830
-56
-0.3% -$57.2K 0.17% 103
2026
Q1
$17.4M Sell
18,886
-2,509
-12% -$2.54M 0.14% 120
2025
Q4
$23M Buy
21,395
+92
+0.4% +$88K 0.19% 112
2025
Q3
$16.3M Sell
21,303
-2,470
-10% -$1.84M 0.14% 127
2025
Q2
$18.5M Sell
23,773
-706
-3% -$549K 0.16% 130
2025
Q1
$20.3M Sell
24,479
-1,403
-5% -$1.17M 0.18% 120
2024
Q4
$20M Sell
25,882
-7,003
-21% -$5.8M 0.17% 125
2024
Q3
$29.1M Sell
32,885
-350
-1% -$315K 0.24% 100
2024
Q2
$30.1M Sell
33,235
-4,762
-13% -$3.81M 0.27% 97
2024
Q1
$29.6M Buy
37,997
+13,083
+53% +$9.31M 0.25% 99
2023
Q4
$14.5M Sell
24,914
-3,655
-13% -$2.13M 0.14% 160
2023
Q3
$15.3M Sell
28,569
-120,994
-81% -$62.3M 0.14% 144
2023
Q2
$70.1M Sell
149,563
-106,652
-42% -$44.7M 0.7% 44
2023
Q1
$88M Buy
256,215
+251,348
+5,164% +$84.8M 0.8% 35
2022
Q4
$1.78M Buy
4,867
+3
+0.1% +$1.06K 0.1% 314
2022
Q3
$1.57M Buy
4,864
+470
+11% +$149K 0.03% 380
2022
Q2
$1.43M Buy
4,394
+5
+0.1% +$1.5K 0.03% 402
2022
Q1
$1.26M Sell
4,389
-155
-3% -$39.9K 0.02% 423
2021
Q4
$1.25M Sell
4,544
-320
-7% -$81.1K 0.02% 427
2021
Q3
$1.12M Sell
4,864
-288
-6% -$71.1K 0.02% 440
2021
Q2
$1.18M Sell
5,152
-418
-8% -$84K 0.02% 438
2021
Q1
$1.04M Sell
5,570
-6,867
-55% -$1.34M 0.02% 448
2020
Q4
$2.1M Buy
12,437
+698
+6% +$104K 0.04% 358
2020
Q3
$1.74M Buy
11,739
+72
+0.6% +$11.1K 0.04% 358
2020
Q2
$1.92M Sell
11,667
-2,096
-15% -$322K 0.05% 338
2020
Q1
$1.91M Buy
13,763
+3,240
+31% +$445K 0.06% 306
2019
Q4
$1.38M Buy
10,523
+6,751
+179% +$783K 0.03% 370
2019
Q3
$422K Sell
3,772
-916
-20% -$102K 0.01% 461
2019
Q2
$520K Sell
4,688
-93
-2% -$11K 0.01% 447
2019
Q1
$620K Buy
4,781
+1,028
+27% +$125K 0.01% 441
2018
Q4
$434K Buy
+3,753
New +$419K 0.01% 453
2018
Q1
Sell
-25,344
Closed -$2.14M 550
2017
Q4
$2.14M Sell
25,344
-365
-1% -$31.1K 0.05% 311
2017
Q3
$2.2M Sell
25,709
-7,998
-24% -$656K 0.05% 288
2017
Q2
$2.77M Buy
33,707
+17,860
+113% +$1.46M 0.07% 241
2017
Q1
$1.33M Buy
15,847
+6,155
+64% +$493K 0.03% 326
2016
Q4
$713K Sell
9,692
-4,026
-29% -$300K 0.02% 387
2016
Q3
$1.1M Sell
13,718
-6,517
-32% -$522K 0.03% 344
2016
Q2
$1.59M Buy
20,235
+624
+3% +$47K 0.04% 303
2016
Q1
$1.41M Buy
19,611
+5,471
+39% +$414K 0.04% 309
2015
Q4
$1.19M Sell
14,140
-11,367
-45% -$943K 0.04% 307
2015
Q3
$2.13M Buy
25,507
+9,535
+60% +$805K 0.07% 227
2015
Q2
$1.33M Sell
15,972
-1,135
-7% -$86.5K 0.04% 290
2015
Q1
$1.24M Sell
17,107
-576
-3% -$41K 0.04% 301
2014
Q4
$1.22M Buy
17,683
+56
+0.3% +$3.78K 0.04% 282
2014
Q3
$1.14M Sell
17,627
-363
-2% -$23K 0.04% 277
2014
Q2
$1.12M Buy
17,990
+50
+0.3% +$2.98K 0.05% 183
2014
Q1
$1.06M Sell
17,940
-505
-3% -$28.2K 0.05% 197
2013
Q4
$940K Sell
18,445
-4,303
-19% -$215K 0.04% 170
2013
Q3
$1.15M Buy
22,748
+4,386
+24% +$230K 0.05% 156
2013
Q2
$903K Buy
+18,362
New +$999K 0.04% 167

Other funds holding LLY

Great Lakes Advisors's LLY Position: Q2 2026 in Review

Great Lakes Advisors reduced its Eli Lilly (LLY) stake by 0.3% in Q2 2026, selling an estimated $57.2K and leaving 18,830 shares worth $22.6M. The position accounts for 0.17% of the portfolio, ranked #103.

Great Lakes Advisors first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $88M in Q1 2023. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Great Lakes Advisors held 18,830 shares of Eli Lilly worth $22.6M as of Q2 2026.
  • Great Lakes Advisors sold 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
  • Eli Lilly made up 0.17% of Great Lakes Advisors's portfolio in Q2 2026, its #103 holding.
  • Great Lakes Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Great Lakes Advisors's Eli Lilly position peaked at $88M in Q1 2023.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.